Please assess the completion status of the following clinical trial:

Trial Title: Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Adults ≥ 40 years of age~* Established clinical history of COPD by ATS/ERS definition~* Former or current smoker \> 10 pack years~* Evidence of dyspnea~Exclusion Criteria:~* Has a respiratory disorder other than COPD~* Cancer not in complete clinical remission~* Clinically significant cardiovascular, neurological, psychiatric, renal, gastro-intestinal, immunological, endocrine, or hematological abnormalities that are uncontrolled

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- FSC (Type: EXPERIMENTAL): Fluticasone propionate/salmeterol combination product 250/50mcg DISKUS twice a day
- SAL (Type: EXPERIMENTAL): Salmeterol 50mcg DISKUS twice a day
- Placebo (Type: PLACEBO_COMPARATOR): Placebo DISKUS twice a day

Based on this trial design, predict the completion outcome and termination type (if applicable).